@IainFrame

Previously CEO of the NCRI and before that Research Director at Diabetes UK and Prostate Cancer UK. Former Trustee of Pancreatic Cancer UK.

 United Kingdom
Joined October 2018
  • Tweets1.8K
  • Following968
  • Followers1.1K
56Media
Conference season is underway, and the @ProstateUK research team will be in attendance to meet and promote our researchers, and find out about the latest developments in the field 🤝🎓 Let us know if you're going to any of the conferences below!
4
1
9
927
Iain Frame 💙 retweeted
Alison Tree 💙@alison_tree1 Mar 2024
Come and join us, to work together towards better outcomes for men with prostate cancer. Free registration, open to all professional groups
National Prostate Cancer Audit@NPCA_uk1 Mar 2024
Registration is open for the NPCA's free Quality Improvement event. 21st March 2024, 3.00-500pm, Online This workshop provides two CPD credits in accordance with the CPD Scheme of The Royal College of Radiologists. @RCRadiologists Go to bit.ly/3wCfNhA to register
The science of performance in prostate radiotherapy and building capacity in prostate cancer care

ALT The science of performance in prostate radiotherapy and building capacity in prostate cancer care

1
3
5
1,752
We are excited to welcome you to the Glasgow Pancreatic Cancer Symposium on Fri 3rd May where you will have the opportunity to hear from superstars like @lauradelongwood, @BarbaraGrnwald, @M_C_Schmid, @graokane, @pilar_acedo and many more! Register here: crukscotlandcentre.ac.uk/mee…
25
3
63
10,738
Today's @JCO_ASCO article reveals a gemcitabine transcriptomic signature, offering efficacy similar to mFOLFIRINOX but with reduced toxicity. This advance is significant for less fit patients, indicating progress in personalized cancer care. ascopubs.org/doi/10.1200/JCO…

Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the...

PURPOSEGemPred, a transcriptomic signature predictive of the efficacy of adjuvant gemcitabine (GEM), was developed from cell lines and organoids and validated retrospectively. The phase III PRODIGE...

ascopubs.org
10
2
29
3,177
On the eve of #worldpancreaticcancerday learn the symptoms 💜 and push for referrals/tests if you think something is wrong. Please sign the petition for a #fasterfairerfunded pathway. #dontwritemeoff @PancreaticCanUK @lgoodbu @precisionpanc @LabSpatialNBJ
Pancreatic Cancer UK@PancreaticCanUK15 Nov 2023
#PancreaticCancer survival rates in the UK are the second lowest in Europe, and among the worst in the world, but five year survival rates could be transformed with a fairer, faster and funded pathway. Sign the petition today: bit.ly/3Qmc3Ih #DontWriteMeOff
1
8
13
937
"There is cause for hope." 💫Be sure to take a look at this short blog which has been written by our Co-Clinical for Oncology, Dr Ganesh Radhakrishna. bit.ly/49FwPum #PancreaticCancerAwarenessMonth @ganeshradhakr12 @PancreaticCanUK @OfficialPCA @AggarwalOnc @NATCAN_news
7
3
13
2,079
Iain Frame 💙 retweeted
Ian Walker
@IanWalker_CRUK7 Nov 2023
Our analysis shows smoking rates go down with regulation. It's vital that MPs from all political parties back the age of sale legislation announced in the #KingsSpeech so today’s children will never smoke. Read more in @thetimes thetimes.co.uk/article/young…

Young Britons half as likely to smoke as their parents were at same age

Young people today are half as likely to smoke as their parents were at the same age, figures show.Only 13 per cent of people aged 16 to 24 smoke cigarettes, c

thetimes.com
1
3
9
802
Iain Frame 💙 retweeted
Rosetrees Trust@RosetreesT7 Nov 2023
Applications are invited for Rosetrees intermediate/major project grants (up to 100k/210k over 3 years respectively) to support innovative biomedical research projects, with established proof of concept, that have the potential for clinical translation. rosetreestrust.co.uk/project…
16
34
8,449
Late stage diagnosis is a big reason why this disease is so often fatal. By recognizing the symptoms, listening to our bodies, and raising concerns with our doctors, we can see early detection and treatment lead us to improved survival rates. Learn more: bit.ly/3odj27w
4
3
306
Iain Frame 💙 retweeted
Simon C
@scserendipity127 Oct 2023
Replying to @AshwinUrol @PCF_Science @WilliamOhMD
So important we talk about ‘practise changing’ but in reality we need to benefit more patients.
1
3
158
Dr. Vinod Balachandran provides the latest data on the mRNA pancreatic cancer vaccine, now headed to a phase II clinical trial. bit.ly/3ZzgaUg

mRNA Pancreatic Cancer Vaccine Trial Heading for Phase II

Dr. Vinod Balachandran provides the latest data on the mRNA pancreatic cancer vaccine, now headed to a phase II clinical trial.

letswinpc.org
2
4
1
20
1,729
There's still time to register for the Innovation in Cancer Care seminar on November 14 book.shsc.scot/shsc/frontend…
7
1
6
1,935
Spending the weekend in Madrid @esmo and absorbing the pancreatic cancer studies, where actually none of them changed the needle. We are re-cycling chemotherapy regimes that have some benefit. There really need to be a call to arms to develop new drugs specifically for pdac!
2
17
819
Replying to @UoM_MRC_DTP
@UoM_MRC_DTP @The_MRC funded #PhD opportunity @FBMH_UoM #colorectalcancer incidence is rising in young #adults globally We are seeking a #PhD candidate to explore #earlydetection of #colorectalcancer in #primarycare findaphd.com/phds/project/mr… #phdlife #phdchat @sSarahBailey
1
12
12
2,123
Iain Frame 💙 retweeted
The ICR@ICR_London23 Oct 2023
📢There has long been a need for tailored guidance on phase I trial protocols and reports. 📄Now, researchers worldwide can use some new guidelines to improve #Research quality and increase shared scientific knowledge. Read more⬇️ icr.ac.uk/news-archive/new-c…
3
2
4
1,940
Iain Frame 💙 retweeted
Marina Parry@marina_parry22 Oct 2023
If you’re at #ESMO23 make sure to go say hi to @JoannaDodkins and talk to her about her work from the National Prostate Cancer Audit @NPCA_uk 👇
Joanna Dodkins@JoannaDodkins22 Oct 2023
Very excited to be presenting work conducted at the National Prostate Cancer Audit demonstrating underutilisation of treatment intensification in mHSPC in England at ESMO 2023 @myESMO @NPCA_uk @NATCAN_news @AggarwalOnc @JanvanderMeule6 @LSHTM
1
3
6
1,071
Fantastic to see this work presented at #ESMO23 this morning! Well done to everyone involved! Congrats @Prof_Nick_James and STAMPEDE, and well done @AttardLab and STRATOSPHere #ProstateCancerUkFunded
Prostate Cancer UK
@ProstateUK22 Oct 2023
🔬 Artificial intelligence (AI) tools could enable men to get prostate cancer treatment that’s more personalised to them, saving and extending lives. These exciting findings are the result of research you helped us fund, in partnership with Movember UK: bit.ly/3tGw8QM
2
11
1,206
Iain Frame 💙 retweeted
Prof Keith Roberts@UHB_HPB19 Oct 2023
Would you like to see standardised radiology reporting of pancreatic cancer in the UK? Read the PACT-UK consensus statement at menti.com code 87536158 if you agree, endorse the statement
1
7
21
2,019
Are you a health and care professional in Scotland interested in learning more about the @NIHRresearch Associate PI Scheme? Secure your space at their educational webinar, Thursday 30 November. Spaces are limited. 👇 eventbrite.com/e/nihr-associ…

NIHR Associate Principal Investigator Scheme Educational Event

Are you a Health and Care professional with an interest in the Associate PI Scheme? If so, this event is tailored just for you!

eventbrite.com
10
3
1,667
Iain Frame 💙 retweeted
The ICR@ICR_London18 Oct 2023
💬🚨"This research proves for the first time that targeting #Myeloid cells can shrink tumours. This suggests we have an entirely new way to treat #ProstateCancer on the horizon.'' - Prof Johann De Bono, Professor in Experimental #CancerMedicine icr.ac.uk/news-archive/scien…
Photo of Prof Johann De Bono

ALT Photo of Prof Johann De Bono

11
2
25
6,661
Load more